Rtw Investments, LP Connect Biopharma Holdings LTD Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $3.25 $250,075 - $1.45 Million	-446,564 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.46 - $5.92 $8,452 - $20,341	-3,436 Reduced 0.76%	446,564 $1.35 Million
Q1 2021 May 14, 2021	BUY	$15.9 - $18.61 $7.16 Million - $8.37 Million	450,000 New	450,000 $8.33 Million

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.